Yu Mi Ahn

1.1k total citations
18 papers, 344 citations indexed

About

Yu Mi Ahn is a scholar working on Organic Chemistry, Molecular Biology and Electrical and Electronic Engineering. According to data from OpenAlex, Yu Mi Ahn has authored 18 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Organic Chemistry, 9 papers in Molecular Biology and 4 papers in Electrical and Electronic Engineering. Recurrent topics in Yu Mi Ahn's work include Synthetic Organic Chemistry Methods (5 papers), Chemical Synthesis and Analysis (4 papers) and Musculoskeletal synovial abnormalities and treatments (3 papers). Yu Mi Ahn is often cited by papers focused on Synthetic Organic Chemistry Methods (5 papers), Chemical Synthesis and Analysis (4 papers) and Musculoskeletal synovial abnormalities and treatments (3 papers). Yu Mi Ahn collaborates with scholars based in United States and South Korea. Yu Mi Ahn's co-authors include Gunda I. Georg, Lakshminarayana Vogeti, Bryan D. Smith, Daniel L. Flynn, Michael D. Kaufman, Wei-Ping Lu, Scott Wise, Subha Vogeti, Cynthia B. Leary and Timothy M. Caldwell and has published in prestigious journals such as Cancer Research, Chemical Communications and The Journal of Organic Chemistry.

In The Last Decade

Yu Mi Ahn

17 papers receiving 328 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu Mi Ahn United States 9 238 159 39 35 32 18 344
Thomas H. Marsilje United States 14 118 0.5× 247 1.6× 64 1.6× 20 0.6× 16 0.5× 21 433
Allison L. Zulli United States 13 195 0.8× 239 1.5× 132 3.4× 19 0.5× 22 0.7× 19 469
Wen‐Liang Dong China 11 254 1.1× 136 0.9× 84 2.2× 14 0.4× 49 1.5× 52 496
Gábor Németh Hungary 11 177 0.7× 194 1.2× 41 1.1× 14 0.4× 14 0.4× 30 508
Masao Morita Japan 10 186 0.8× 128 0.8× 18 0.5× 25 0.7× 14 0.4× 44 450
Tao Cai China 11 143 0.6× 276 1.7× 71 1.8× 26 0.7× 6 0.2× 30 501
Scott A. Watkins United States 9 177 0.7× 192 1.2× 117 3.0× 47 1.3× 20 0.6× 11 404
Andrew G. Roberts United States 12 181 0.8× 394 2.5× 16 0.4× 29 0.8× 33 1.0× 29 692
Susumu Yamamoto Japan 12 133 0.6× 90 0.6× 50 1.3× 12 0.3× 26 0.8× 40 413
Tadashi Terasaka Japan 10 76 0.3× 220 1.4× 34 0.9× 12 0.3× 19 0.6× 20 350

Countries citing papers authored by Yu Mi Ahn

Since Specialization
Citations

This map shows the geographic impact of Yu Mi Ahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Mi Ahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Mi Ahn more than expected).

Fields of papers citing papers by Yu Mi Ahn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Mi Ahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Mi Ahn. The network helps show where Yu Mi Ahn may publish in the future.

Co-authorship network of co-authors of Yu Mi Ahn

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Mi Ahn. A scholar is included among the top collaborators of Yu Mi Ahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Mi Ahn. Yu Mi Ahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
Caldwell, Timothy M., Yu Mi Ahn, Stacie L. Bulfer, et al.. (2022). Discovery of vimseltinib (DCC-3014), a highly selective CSF1R switch-control kinase inhibitor, in clinical development for the treatment of Tenosynovial Giant Cell Tumor (TGCT). Bioorganic & Medicinal Chemistry Letters. 74. 128928–128928. 19 indexed citations
3.
Caldwell, Timothy M., Michael D. Kaufman, Scott Wise, et al.. (2022). Discovery of acyl ureas as highly selective small molecule CSF1R kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 74. 128929–128929. 7 indexed citations
4.
5.
Smith, Bryan D., Michael D. Kaufman, Scott Wise, et al.. (2021). Vimseltinib: A Precision CSF1R Therapy for Tenosynovial Giant Cell Tumors and Diseases Promoted by Macrophages. Molecular Cancer Therapeutics. 20(11). 2098–2109. 40 indexed citations
6.
Smith, Bryan D., Lakshminarayana Vogeti, Anu Gupta, et al.. (2019). Abstract B129: Preclinical studies with DCC-3116, an ULK kinase inhibitor designed to inhibit autophagy as a potential strategy to address mutant RAS cancers. Molecular Cancer Therapeutics. 18(12_Supplement). B129–B129. 6 indexed citations
7.
Ahn, Yu Mi, Michael Clare, Carol L. Ensinger, et al.. (2010). Switch control pocket inhibitors of p38-MAP kinase. Durable type II inhibitors that do not require binding into the canonical ATP hinge region. Bioorganic & Medicinal Chemistry Letters. 20(19). 5793–5798. 26 indexed citations
8.
Ahn, Yu Mi, Lakshminarayana Vogeti, Hari Krishna R. Santhapuram, et al.. (2006). Design, synthesis, and antiproliferative and CDK2-cyclin a inhibitory activity of novel flavopiridol analogues. Bioorganic & Medicinal Chemistry. 15(2). 702–713. 29 indexed citations
9.
10.
Diederich, Wibke E., Patrick T. Flaherty, Craig J. Mossman, et al.. (2003). Formal Total Synthesis of (+)-Salicylihalamides A and B:  A Combined Chiral Pool and RCM Strategy. The Journal of Organic Chemistry. 68(26). 10030–10039. 22 indexed citations
11.
Ahn, Yu Mi, David G. Vander Velde, & Gunda I. Georg. (2002). Synthetic Studies with 13-Deoxybaccatin III. The Journal of Organic Chemistry. 67(20). 7140–7143. 9 indexed citations
12.
13.
Ahn, Yu Mi, et al.. (2001). A Convenient Method for the Efficient Removal of Ruthenium Byproducts Generated during Olefin Metathesis Reactions. Organic Letters. 3(9). 1411–1413. 142 indexed citations
14.
Georg, Gunda I., Yu Mi Ahn, Farhad Farokhi, et al.. (2001). Short and efficient chiral pool and RCM approach towards the synthesis of the macrocyclic core of the salicylihalamides. Chemical Communications. 255–256. 11 indexed citations
15.
16.
Ahn, Yu Mi, et al.. (1990). [2+2+2] Cycloaddition reaction of 1-methylpyrrole with diethyl azodicarboxylate. The Journal of Organic Chemistry. 55(12). 3957–3958. 3 indexed citations
17.
Lee, Chang Kiu & Yu Mi Ahn. (1989). Differences in reactions of vinyl derivatives of pyrrole and thiophene with acetylenic esters. Journal of Heterocyclic Chemistry. 26(2). 397–400. 2 indexed citations
18.
Lee, Chang Kiu & Yu Mi Ahn. (1989). Reactions of amides with potassium permanganate in neutral aqueous solution. The Journal of Organic Chemistry. 54(15). 3744–3747. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas H. Marsilje Breakdown of academic impact, for papers by Allison L. Zulli Breakdown of academic impact, for papers by Wen‐Liang Dong Breakdown of academic impact, for papers by Gábor Németh Breakdown of academic impact, for papers by Masao Morita Breakdown of academic impact, for papers by Tao Cai Breakdown of academic impact, for papers by Scott A. Watkins Breakdown of academic impact, for papers by Andrew G. Roberts Breakdown of academic impact, for papers by Susumu Yamamoto Breakdown of academic impact, for papers by Tadashi Terasaka
Rankless by CCL
2026